Atovaquone‐Proguanil Versus Mefloquine for Malaria Prophylaxis in Nonimmune Travelers: Results from a Randomized, Double‐blind Study
Open Access
- 1 March 2007
- journal article
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 14 (2) , 92-95
- https://doi.org/10.1111/j.1708-8305.2007.00116.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Safety of Atovaquone/Proguanil in Long-Term Malaria Prophylaxis of Nonimmune AdultsJournal of Travel Medicine, 2006
- Post-Marketing Surveillance: Adverse Events during Long-Term Use of Atovaquone/Proguanil for Travelers to Malaria-Endemic CountriesJournal of Travel Medicine, 2006
- Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquineBritish Journal of Clinical Pharmacology, 2004
- Atovaquone‐Proguanil versus Mefloquine for Malaria Prophylaxis in Nonimmune Travelers: Results from a Randomized, Double‐Blind StudyClinical Infectious Diseases, 2001
- Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind studyThe Lancet, 2000
- Health Problems After Travel to Developing CountriesThe Journal of Infectious Diseases, 1987
- Trips to the South—a Health Hazard: Morbidity of Finnish TravellersScandinavian Journal of Infectious Diseases, 1983
- Infection and travel: The experience of package tourists and other travellersJournal of Infection, 1980
- Study of Illness among Americans Returning from International Travel, July 11-August 24, 1971 (Preliminary Data)The Journal of Infectious Diseases, 1972